Dr. Lakshmi Boyapati, MD

Dr. Boyapati practices at Corewell Health Pennock Hospital in Hastings, Michigan, part of Corewell Health.

Dr. Boyapati's NPI, 1205290194, was assigned on April 7, 2016. Dr. Boyapati holds Florida license ME159111.

Dr. Boyapati's primary practice is Corewell Health Pennock Hospital, at 1009 W Green St, Hastings, MI 49058 in Barry County. The practice phone is (269) 945-3451.

Dr. Boyapati's primary practice is Corewell Health Pennock Hospital in Hastings, Michigan, part of Corewell Health. Dr. Boyapati is also affiliated with Corewell Health Grand Rapids Hospitals - Butterworth. The medical group on file is Brookdale University Hospital and Medical Center. Dmand AI also links Dr. Boyapati to 4 more hospitals, 10 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boyapati practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Boyapati's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Boyapati is licensed in Florida.

CMS data shows 2,523 Medicare services from Dr. Boyapati across 14 procedure codes in 2024, for 281 Medicare patients. Medicare paid $71,177 for them.

CMS counts 281 Medicare patients who saw Dr. Boyapati in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Boyapati's median patient age at 71, with 57% women.

In 2024, Dr. Boyapati wrote 504 Medicare Part D claims for 113 patients. 78% of them were for generic drugs. CMS names the drug for 383 of them, across 14 drugs with 11 or more claims each, at $679,472 in total drug cost. In 2023, CMS named 25 claims across 2 drugs.

Dr. Boyapati accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Boyapati as offering telehealth.

Dmand AI links 4 papers to Dr. Boyapati, published from 2019 to 2024. Dr. Boyapati's most frequent co-authors are Gardith Joseph, MD, Beka Aroshidze, MD and Preethi Ramachandran, MD.

CMS Open Payments shows 87 general payments to Dr. Boyapati from 28 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 80% of the total. Seagen Inc. paid the most, $319.